Alexandros Makriyannis All Experts

George D. Behrakis Chair in pharmaceutical biotechnology, director of the Center for Drug Discovery, professor of chemistry and chemical biology

Expertise

Contact

a.makriyannis@neu.edu

617.373.4200

Alexandros Makriyannis In the Media

Alexandros Makriyannis for Northeastern

Cannabis will transform medicine—once we figure out how to get rid of its side effects

To produce better drugs for chronic pain, mental illness, and other health problems, Northeastern professor Alexandros Makriyannis is making new molecules in the lab—the same kind that give people a high when they smoke marijuana.
- by Roberto Molar Candanosa February 19, 2020
Structure of the brain’s ‘marijuana receptor’ revealed

New research by an interdisciplinary team, including Northeastern’s Alexandros Makriyannis, reveals how THC—the psychoactive ingredient in marijuana—gets into brain cells. The findings open the door to the development of new medications, free from side effects, for conditions from pain and obesity to neurological diseases and addiction.
- by Thea Singer October 20, 2016
Drug discovery and delivery research at Northeastern’s pharmacy school spurs innovation, collaboration

Throughout Northeastern’s School of Pharmacy, researchers are making progress in solving a range of pressing health challenges.
- by Greg St. Martin November 12, 2015
An off-switch for drugs’ toxic side effects

New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
- by Angela Herring June 19, 2014

X

Cookies on Northeastern sites

This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.